Adalvo is a leading B2B pharmaceutical company in Europe, specialising in Active Pharmaceutical Ingredients (APIs) and Biopharmaceuticals. With a presence in over 100 countries and more than 110 global partners, Adalvo is committed to improving patient care by delivering high-quality products and services through a smart collaboration network. The company’s unique approach is tailored to meet the specific needs of each partner, helping them to grow their business and achieve their objectives, whether that involves increasing revenue or expanding into new markets. Adalvo prioritises employee development and community growth, and strives for excellence in all its endeavours.

Services include:
– APIs (Active Pharmaceutical Ingredients)
– Biologics

Adalvo’s commitment to excellence and making a difference ensures that it plays a vital role in the pharmaceutical industry. For more information, visit adalvo.com.